This 2.7-fold increase in nuclear PPARα was accompanied by almost 4-fold increase in PPAR-transcriptional activity (Fig. 1D), further supporting the possibility of using fenofibrate to trigger PPARα-mediated responses in Glioma cells. This evidence concerns the gene PPARA and central nervous system cancer.